<DOC>
	<DOCNO>NCT00953017</DOCNO>
	<brief_summary>Miralax ( PEG 3350 ) show safe uncomplicated bowel preparation prior colonoscopy pediatric population . This study seek confirm efficacy bowel cleanse regimen adult determine benefit add pretreatment medication bowel preparation . The tolerability Miralax hopefully improve patient satisfaction colonoscopy decrease reluctance screen uncomfortable taste side effect bowel preparation regimen .</brief_summary>
	<brief_title>A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely Bowel Cleansing Prior Colonoscopy</brief_title>
	<detailed_description />
	<mesh_term>Lubiprostone</mesh_term>
	<mesh_term>Bisacodyl</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>adult patient refer clinic average increase risk screen colorectal cancer elevate serum creatinine ( Men &gt; 1.4mg/dL , Women &gt; 1.3mg/dL ) previous diagnosis congestive heart failure history bowel obstruction history solid organ transplant current pregnancy lactate mother participant allergic either polyethylene glycol ( Miralax ) , lubiprostone ( Amitiza ) , bisacodyl ( Dulcolax )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Efficacy bowel cleanse</keyword>
	<keyword>Patient tolerability</keyword>
	<keyword>Amitiza</keyword>
	<keyword>Dulcolax</keyword>
	<keyword>Miralax</keyword>
	<keyword>Colonoscopy preparation</keyword>
	<keyword>Bowel preparation</keyword>
	<keyword>Screening colonoscopy</keyword>
</DOC>